LBA1 Denosumab added to 2 different nab-paclitaxel regimens as neoadjuvant therapy in patients with primary breast cancer: Time to event analysis from the GeparX 2 × 2 randomized clinical trial

Saved in:
Bibliographic Details
Published in:ESMO open 2024-05, Vol.9, p.103478, Article 103478
Main Authors: Loibl, S., Reinisch, M., Just, M., Untch, M., Stoetzer, O.J., Schneeweiss, A., Fasching, P.A., Wimberger, P., Seiler, S., Huober, J., Thill, M., Rhiem, K.E., Solbach, C., Hanusch, C., Denkert, C., Engels, K., Filmann, N., Holtschmidt, J., Blohmer, J-U., Link, T.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2059-7029
2059-7029
DOI:10.1016/j.esmoop.2024.103478